Search

everythinglearnresearchcommunity

for

Search:↓

Alopecia areata affects many in the US, impacting quality of life, with limited treatment options.

Higher antigliadin antibodies are linked to more severe alopecia areata, suggesting screening for celiac disease in these patients.

DFMO may help control hair growth and treat cancer.

Frontal fibrosing alopecia in men is often misdiagnosed and needs better diagnostic criteria and treatments.

The CD44-CD49d complex boosts T cell activation and survival in autoimmune disease.

New drugs, baricitinib and ritlecitinib, are effective for severe alopecia areata.

Cosmetic treatments can replenish key amino acids in damaged hair, improving its strength and appearance.

Facial care products are not linked to causing frontal fibrosing alopecia.

A new type of rapid hair loss called ADTA usually gets better on its own within 6 months.

Men with Frontal fibrosing alopecia typically lose hair on the front scalp and sometimes on sideburns and upper lip, with treatments showing varied success.

Laser treatment, especially when combined with other therapies, is effective for hair regrowth in alopecia areata.

Trichoscopy helps diagnose frontal fibrosing alopecia, even with unusual patterns.

UV-induced autofluorescence is effective for identifying different types of alopecia.

Oral difelikefalin significantly reduces itch in notalgia paresthetica.

Both baricitinib and tofacitinib effectively reduce alopecia areata severity, with tofacitinib showing more improvement over longer use.

Frontal fibrosing alopecia and vitiligo might be linked by similar immune issues.

Smoking doesn't cause or prevent Frontal Fibrosing Alopecia, hormonal imbalance may be involved, and a combination of antiandrogens and steroids can help stabilize the condition.

New criteria for diagnosing frontal fibrosing alopecia include specific scalp and eyebrow hair loss as major factors and other hair loss areas and hair analysis as minor factors.

Allergies, especially both seasonal and food, increase the risk of developing alopecia areata.

Tofacitinib effectively treated severe hair loss in a patient who didn't respond to other treatments.

Hair transplantation may not work for Frontal Fibrosing Alopecia as transplanted hair was lost when the disease came back.

Dermoscopy effectively distinguishes between acute total hair loss and other types of female hair loss.

Two trichoscopic patterns found in hair loss: diffuse fibrotic and androgenetic alopecia, affecting treatment choice and regrowth chances.

The document suggests a possible link between frontal fibrosing alopecia and rosacea.

Tofacitinib is effective and safe for treating alopecia areata.

The study concluded that a 'Swiss cheese' pattern in hair follicles is a useful sign for diagnosing alopecia areata.

Most treatments for Frontal Fibrosing Alopecia are ineffective, but early anti-inflammatory therapy may help and the condition may stabilize over time.

A new classification and scoring system is needed for alopecia areata to better assess severity.

Tofacitinib, a JAK inhibitor, improved hair regrowth in most patients with severe alopecia areata and had minimal side effects.

Early diagnosis and a multidisciplinary approach are crucial for managing Frontal Fibrosing Alopecia.